87 related articles for article (PubMed ID: 12877998)
1. Intrasteric regulation of MDM2.
Shimizu H; Hupp TR
Trends Biochem Sci; 2003 Jul; 28(7):346-9. PubMed ID: 12877998
[No Abstract] [Full Text] [Related]
2. p53-Mdm2--the affair that never ends.
Alarcon-Vargas D; Ronai Z
Carcinogenesis; 2002 Apr; 23(4):541-7. PubMed ID: 11960904
[TBL] [Abstract][Full Text] [Related]
3. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
4. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
Unger T; Juven-Gershon T; Moallem E; Berger M; Vogt Sionov R; Lozano G; Oren M; Haupt Y
EMBO J; 1999 Apr; 18(7):1805-14. PubMed ID: 10202144
[TBL] [Abstract][Full Text] [Related]
5. Cancer: pinning a change on p53.
Ryan KM; Vousden KH
Nature; 2002 Oct; 419(6909):795, 797. PubMed ID: 12397340
[No Abstract] [Full Text] [Related]
6. Mdm2 association with p53 targets its ubiquitination.
Fuchs SY; Adler V; Buschmann T; Wu X; Ronai Z
Oncogene; 1998 Nov; 17(19):2543-7. PubMed ID: 9824166
[TBL] [Abstract][Full Text] [Related]
7. Exploiting the p53 pathway for cancer diagnosis and therapy.
Lane DP
Br J Cancer; 1999 Jul; 80 Suppl 1():1-5. PubMed ID: 10466753
[No Abstract] [Full Text] [Related]
8. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
[TBL] [Abstract][Full Text] [Related]
9. MDM2, an introduction.
Iwakuma T; Lozano G
Mol Cancer Res; 2003 Dec; 1(14):993-1000. PubMed ID: 14707282
[TBL] [Abstract][Full Text] [Related]
10. Mdm2-SUMO1: is bigger better?
Melchior F; Hengst L
Nat Cell Biol; 2000 Sep; 2(9):E161-3. PubMed ID: 10980713
[No Abstract] [Full Text] [Related]
11. Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets?
Fischer PM; Lane DP
Trends Pharmacol Sci; 2004 Jul; 25(7):343-6. PubMed ID: 15219971
[No Abstract] [Full Text] [Related]
12. Mini p53.
Ferrier V
Nat Cell Biol; 2002 Jun; 4(6):E156. PubMed ID: 12042832
[No Abstract] [Full Text] [Related]
13. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
[TBL] [Abstract][Full Text] [Related]
14. Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction.
Hardcastle IR; Ahmed SU; Atkins H; Calvert AH; Curtin NJ; Farnie G; Golding BT; Griffin RJ; Guyenne S; Hutton C; Källblad P; Kemp SJ; Kitching MS; Newell DR; Norbedo S; Northen JS; Reid RJ; Saravanan K; Willems HM; Lunec J
Bioorg Med Chem Lett; 2005 Mar; 15(5):1515-20. PubMed ID: 15713419
[TBL] [Abstract][Full Text] [Related]
15. Mdm2: keeping p53 under control.
Piette J; Neel H; Maréchal V
Oncogene; 1997 Aug; 15(9):1001-10. PubMed ID: 9285554
[TBL] [Abstract][Full Text] [Related]
16. The MDM2-p53 interaction.
Moll UM; Petrenko O
Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of the human MDM2 p53 binding domain by fusion to a p53 transactivation peptide.
Liu Z; Olejniczak ET; Fesik SW
Protein Expr Purif; 2004 Oct; 37(2):493-8. PubMed ID: 15358376
[TBL] [Abstract][Full Text] [Related]
18. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Vassilev LT; Vu BT; Graves B; Carvajal D; Podlaski F; Filipovic Z; Kong N; Kammlott U; Lukacs C; Klein C; Fotouhi N; Liu EA
Science; 2004 Feb; 303(5659):844-8. PubMed ID: 14704432
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
20. Mdm2 promotes the rapid degradation of p53.
Haupt Y; Maya R; Kazaz A; Oren M
Nature; 1997 May; 387(6630):296-9. PubMed ID: 9153395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
